Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Treasury Shares (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Treasury Shares for 6 consecutive years, with $2470.0 as the latest value for Q2 2020.

  • Quarterly Treasury Shares fell 84.69% to $2470.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $2470.0 through Jun 2020, down 84.69% year-over-year, with the annual reading at $2470.0 for FY2019, 84.69% down from the prior year.
  • Treasury Shares for Q2 2020 was $2470.0 at Outlook Therapeutics, roughly flat from $2470.0 in the prior quarter.
  • The five-year high for Treasury Shares was $1.2 million in Q4 2016, with the low at $2470.0 in Q3 2019.
  • Average Treasury Shares over 5 years is $442080.3, with a median of $117485.0 recorded in 2017.
  • The sharpest move saw Treasury Shares surged 59.29% in 2016, then tumbled 98.09% in 2019.
  • Over 5 years, Treasury Shares stood at $1.2 million in 2016, then crashed by 74.73% to $309532.0 in 2017, then plummeted by 58.29% to $129095.0 in 2018, then crashed by 98.09% to $2470.0 in 2019, then changed by 0.0% to $2470.0 in 2020.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2470.0, $2470.0, and $2470.0 for Q2 2020, Q4 2019, and Q3 2019 respectively.